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Introduction: Mesenchymal stem cells have been increasingly used for cell-based therapies. Adipose-derived
stem/stromal cells (ASCs) from the stromal vascular fraction (SVF) of fat tissue are a particularly attractive option
for cell based therapy given their accessibility and relative abundance. However, their application in both clinical
and basic science investigations is complicated by the isolation of differentiable cells within the SVF. Current enrichment
strategies, such as monolayer passaging and surface marker-based sorting, can be time-consuming or overly stringent.
Ideally, a population of cells with great regenerative capacity could be isolated with high yields so that extensive in vitro
manipulation is not necessary. The objective of this study was to determine whether SVF cells sorted based on expression
of alkaline phosphatase liver/bone/kidney (ALPL) resulted in populations with increased osteogenic
differentiation potential.
Methods: SVF samples were obtained from four, human donors and processed to isolate initial, heterogeneous
cell populations. These SVF cells underwent a four day osteogenic priming period, after which they were treated
with a fluorescent, oligodeoxynucleotide molecular beacon probe specific for ALPL mRNA. Cells were separated
into positive and negative groups using fluorescence-activated cell sorting (FACS) then differentiated down the
osteogenic lineage. Differentiation was assessed by measuring calcified matrix production in each sample.
Results: Cells positive for ALPL expression (ALPL+) represented approximately 34% of the gated population,
while cells negative for ALPL expression (ALPL-) represented approximately 18%. ALPL+ cells produced 3.7-fold
and 2.1-fold more calcified matrix than ALPL- and unsorted SVF cells, respectively, indicating a significant
improvement in osteogenic differentiation. Further, ALPL+ cells showed increases in metabolite production for
both adipogenesis and chondrogenesis, suggesting that the enrichment process yields an enhanced multipotent
phenotype. Osteogenic differentiation response and cell yields for ALPL+ cells were markedly improved over surface
marker-sorted samples.
Conclusion: This study demonstrates a novel method to enrich heterogeneous SVF cells for increased osteogenic
potential. The procedure requires less time and results in higher yields of therapeutically useful cells than other existing
approaches. Gene expression-based sorting of MSCs is a potentially paradigm-shifting approach that could benefit
applications spanning from basic science to clinical therapy.* Correspondence: Eric_Darling@brown.edu
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Cell enrichment or purification is often a necessary first
step for clinical, cell-based therapies as well as basic sci-
ence investigations into homogeneous subpopulations.
Adult mesenchymal stem cells (MSCs) are one type of cell
for which this is of great importance. As our understand-
ing of MSCs improves, their use in regenerative medicine
becomes ever more promising. This has been especially
true for musculoskeletal tissues, with researchers pro-
posing many possibilities using MSCs for the treat-
ment of orthopedic ailments [1-7]. Autologous stemcell transplantation therapies have been proposed for their
potential therapeutic versatility and low immunogenicity
[8,9]. However, many of these proposed therapies rely on
prior in vitro expansion of the cell populations, which is a
slow process and can negatively affect cell phenotype [10].
Single-surgery therapies, where autologous MSCs are iso-
lated and reintroduced into the site of injury in short suc-
cession, have the potential to save on both costs and
rehabilitation time. Human adipose-derived stem/stromal
cells (ASCs), isolated from the stromal vascular fraction
(SVF) of lipoaspirate, may be particularly well suited for
such single-surgery strategies due to their accessibility and
relative abundance in fat tissue, as well as their ability to
differentiate down the osteogenic, adipogenic, and chon-
drogenic lineages [11].
While prolonged culture and passaging is an effective
method for isolating ASCs from SVF populations, this
process can take weeks to complete. A more rapid ap-
proach for the isolation of regeneratively advantageous
cells from other cell types contained within the SVF
would be enormously beneficial. Traditional cell enrich-
ment strategies have found limited success purifying
MSCs due to the lack of a universal surface marker profile
[12]. This approach is further complicated by the temporal
variability of surface antigens, which can change over time
with passaging [13]. Additionally, reported surface marker
profiles often result in very low cell yields, necessitating
post-sort expansion to obtain sufficient cell numbers for
practical applications [14]. Discarded SVF cells can in-
clude mesenchymal and endothelial progenitors that may
have the potential to differentiate down a subset of line-
ages [15,16]. Rigorous surface marker definitions that have
been proposed in the literature or by organizations such
as the International Federation for Adipose Therapeutics
and the International Society for Cellular Therapy may
be unnecessarily restrictive for therapeutic applications
since they exclude a large fraction of cells with regen-
erative potential [17].
Alternative enrichment strategies are needed to sort
large numbers of therapeutically beneficial cells from the
SVF. We thus propose a cell sorting scheme based on
expression of mRNA, using molecular beacons as fluorescent
reporters. A molecular beacon is an oligodeoxynucleotide,
hairpin-shaped, hybridization probe with a fluorophore on
the 5′ end and a quencher on the 3′ end [18]. The probe
fluorescence is quenched in the absence of target oligo-
nucleotide but is unquenched when the loop region binds
to its target mRNA. Other groups have used molecular
beacons in conjunction with fluorescence-activated cell
sorting (FACS) to sort embryonic stem cells based on
OCT4 and SOX2 expression for stemness and pluripotent
stem cells based on MHC and TNNT gene families for
cardiomyogenesis [19-21]. Given previous successes using
molecular beacons with pluripotent stem cells, we apply
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erogeneous mesenchymal cell population, the SVF.
The objective of this study was to sort cells derived
from the SVF of adipose tissue based on expression of
alkaline phosphatase liver/bone/kidney (ALPL) to obtain
subpopulations of cells capable of enhanced osteogen-
esis. To do this, we employed a custom-designed mo-
lecular beacon for ALPL in combination with FACS [22].
This approach produced high-yield isolations of cellular
subpopulations capable of significantly enhanced osteo-
genesis compared with both unsorted SVF cells and
surface-marker sorted ASCs, suggesting increased thera-
peutic potential for bone regeneration therapies.
Materials and Methods
Cell isolation, culture, and multipotency assessment
Media compositions
Cells were cultured in defined media that served to either
maintain stemness, act as a control condition, or induce a
differentiation response. Stromal medium, which acted as
a control condition, contained Dulbecco’s modified Eagle’s
medium (DMEM) with Ham’s F12 salt solution in a 1:1
ratio, 10% fetal bovine serum (FBS) (Zen-Bio, Research
Triangle Park, NC, USA), and 1% antibiotic/antimycotic
(Fisher Scientific, Pittsburgh, PA, USA). Expansion medium
contained stromal medium, with the addition of 5 ng/ml
epidermal growth factor, 1 ng/ml fibroblast growth factor,
and 0.25 ng/ml transforming growth factor beta-1 (R&D
Systems, Minneapolis, MN, USA) to maintain cellular
proliferation and multipotency characteristics [10]. Osteo-
genic differentiation medium contained DMEM with high
glucose (4.5 g/l), 10% FBS, 1% antibiotic/antimycotic, 1
nM dexamethasone, 21.6 mg/ml β-glycerophosphate,
50 μg/ml ascorbate-2-phosphate, and 10 μg/ml vitamin
D3 (Sigma-Aldrich, St. Louis, MO, USA) [23]. Osteogenic
differentiation medium also acted as the priming medium
to induce ALPL expression prior to sorts. Adipogenic dif-
ferentiation medium contained DMEM/F-12, 10% FBS,
1% antibiotic/antimycotic, 10 μg/ml insulin, 0.39 μg/ml
dexamethasone, 55.6 μg/ml isobutyl-1-methylxanthine
(Sigma-Aldrich), and 17.5 μg/ml indomethacin (Cayman
Chemical, Ann Arbor, MI, USA) [23]. Chondrogenic
differentiation medium contained DMEM with high
glucose, 10% FBS, 1% antibiotic/antimycotic, 10 ng/ml
transforming growth factor beta-1, 50 μg/ml ascorbate-2-
phosphate, 39.0 ng/ml dexamethasone, and 1% insulin –
transferrin– selenium+ premix (BD Biosciences, San Diego,
CA, USA) [24].
Adipose-derived stromal cell isolation
All procedures involving human donors were approved
by the institutional review board of Rhode Island Hospital.
Donors provided consent to use surgical waste material
for research purposes. SVF cells were isolated from thesubcutaneous adipose tissue of human, female donors
(N = 4) following established protocols [24]. Briefly,
250 ml liposuction waste tissue was washed with warm
phosphate-buffered saline at pH 7.4 and digested with a
solution of 0.1% w/v collagenase solution in 1% v/v bovine
serum albumin fraction V (Invitrogen, Grand Island, NY,
USA) and 2 mM calcium chloride for 60 minutes. Re-
leased cells were washed four times with stromal medium,
and then incubated for 10 minutes in red blood cell lysis
buffer containing 155 mM ammonium chloride, 10 mM
potassium carbonate, and 0.1 mM ethylenediamine tetraa-
cetic acid. The resultant cells were then stained with trypan
blue and counted using a hemocytometer to determine via-
bility and cell yield. Isolated cells were cryogenically stored
in freezing medium containing 10% dimethylsulfoxide, 10%
DMEM:Ham’s F12 salt solution, and 80% FBS at a concen-
tration of 5 × 106 to 6 × 106 cells/ml. For designated pre-
liminary/pilot studies, an ASC superlot containing cells
from seven nondiabetic donors between the ages of 18 and
60 was purchased commercially and grown to passage 4
before use in experiments (Zen-Bio).
Multilineage differentiation
To determine general multipotency of donor cells, pri-
mary SVF cells were seeded in 96-well plates (Genesee
Biomedical, Denver, CO, USA) at 8,000 to 10,000 cells/
well and differentiated down the osteogenic and adipo-
genic lineages using the differentiation media described
previously (n = 4 for each lineage and corresponding
control). For chondrogenic differentiation, 50,000 cells/
well were seeded in a V-bottomed 96-well plate and cen-
trifuged at 400 × g to form cell pellets [24]. The cell pellets
were then given chondrogenic differentiation medium
to induce chondrogenesis or stromal medium to act as a
control (n = 4). Samples were cultured for either 2 weeks
(adipogenic) or 3 weeks (osteogenic, chondrogenic) be-
fore being assessed for lineage-specific metabolites as
described below.
Assessment of osteogenesis, adipogenesis, and
chondrogenesis
For osteogenesis, samples at 21 days were fixed with 4%
paraformaldehyde and stained with alizarin red S, which
binds to calcified matrix and is indicative of bone forma-
tion (Sigma-Aldrich). For quantification, the dye was
eluted using 10% cetylpyridinium chloride, and the ab-
sorbance of the eluent was measured at 540 nm. For adi-
pogenesis, samples at 14 days were fixed and stained
with oil red O (Sigma-Aldrich), a dye that binds intracel-
lular lipids indicative of fat formation. For quantification,
the stain was eluted from fixed cells using 100% isopro-
panol, and the absorbance of the eluents was measured
at 500 nm. To report elution data on a per-cell basis, cell
numbers in each sample were quantified by counting
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Gen5 (BioTek U.S., Winooski, VT, USA) or CellProfiler
software [25]. For chondrogenesis, samples at 21 days
were digested with 125 μg/ml papain at 65°C and pH 6.5
for 24 hours (Sigma-Aldrich). The sulfated glycosamino-
glycan (sGAG) content of each digested pellet was quan-
tified using the dimethylmethylene blue assay, modified
from established protocols [26,27]. Briefly, 2.1 mg dimethyl-
methylene blue was dissolved in 1 ml of 100% ethanol and
10 ml of 0.3 M HCl containing 304 mg glycine and 237 mg
sodium chloride. The resulting solution was brought to a
volume of 100 ml with deionized water, and the pH of the
dimethylmethylene blue dye solution was adjusted to 1.5
using 6 M HCl to account for nonstandard DNA content
contributions across samples [28]. Then 200 μl dye was
added to 50 μl digest solution, and the absorbance of the
resulting mixture was measured at 525 nm. The Pico-
Green assay (Invitrogen, Carlsbad, CA, USA) was used to
quantify DNA amounts using 100 μl each digest following
the manufacturer’s protocol (480 nm excitation, 520 nm
emission). A standard curve was used to calculate the total
sGAG amount in each pellet, which was then normalized
on a per-DNA basis.Beacon design, gene expression-based sorting, and
differentiation of sorted cells
ALPL molecular beacon design, osteogenic priming, and
molecular beacon treatment
A custom-designed molecular beacon targeting human
ALPL, an early marker of osteogenesis [29], was developed
as part of our previous work [22]. The beacon sequence
was (stems italicized): 5′-(6-carboxyfluorescein) CGCTCC
AGAGTGTCTTCCGAGGAGGTCAA GGAGCG (Black
Hole Quencher 1)-3′ (melting temperature, 69.4°C; Euro-
fins MWG Operon, Huntsville, AL, USA). Freshly thawed,
primary SVF cells (and passage 4 superlot ASCs, for pilot
studies) were seeded in monolayer at 33,000 cells/cm2 and
given either osteogenic differentiation medium to prime
osteogenic gene expression (primed cells) or expansion
medium to maintain their undifferentiated state (non-
primed cells). After 4 days, primed and nonprimed cells
were trypsinized using 0.25% trypsin–ethylenediamine tet-
raacetic acid (Fisher Scientific) and separately resuspended
in nonsupplemented base medium (DMEM:Ham’s F12
salt solution) at a concentration of 1 × 106 cells/100 μl.
ALPL molecular beacons were added to both cell suspen-
sions at a final concentration of 1 μM immediately prior
to electroporation. Beacon-treated cells were electropo-
rated using an Amaxa Nucleofector according to manu-
facturer’s instructions (program U-23; Lonza AG, Basel,
Switzerland). When the process was complete, the cuvette
was removed and gently rinsed with 500 μl stromal
medium three times to collect all cells in a total of 1.5 mlmedium. The cells were allowed to recover for 60 minutes
in a humidified 37°C, 5% carbon dioxide incubator. Cells
were then pelleted by centrifugation at 400 × g for 5 mi-
nutes and subsequently resuspended at a concentration of
10 × 106 cells/ml in warm Hank’s Buffered Salt Solution
(Fisher Scientific) for FACS. Samples were protected from
light prior to sorting. All sorts were initiated within 1 hour
of electroporation. The overall experimental design for the
study is illustrated in Figure 1.Gene expression-based fluorescence-activated cell sorting
SVF cells were sorted based on positive versus negative
signals for ALPL using the previously mentioned mo-
lecular beacon. All gene expression-based sorts were
performed on a BD FACSAria IIu instrument (BD Bio-
sciences). Cell samples (primed and nonprimed) treated
with ALPL beacon were sorted following standard FACS
protocols. The instrument was outfitted with an extra-
wide 100 μm nozzle to minimize cellular shear stress
during the sorting procedure. The forward scatter
threshold was set at 5,000 units. Cells were sorted by
FACS into positive (ALPL+) and negative (ALPL–) popu-
lations using a 488 nm laser and a 530/30 bandpass filter
for detection. In every sorting experiment, cells that
were not treated with any molecular beacons were used
to set gates defining threshold fluorescence levels (that
is, all untreated cells were negative, and all intensities
above that level were positive). Primed, unsorted cells
from the initial SVF population that were not treated
with beacons were used as controls for the study. Non-
primed, unsorted cells were not analyzed as part of the
main study; however, that condition was analogous to
the general multipotency tests conducted for each donor.
A mock sort was also conducted with Donor 4 SVF cells
using only forward and side scatter parameters to demon-
strate that the initial gating process had no influence on
osteogenesis (see Additional file 1). Sort data were ana-
lyzed using FlowJo FACS analysis software (TreeStar, Inc.,
Portland, OR, USA).Cell seeding and differentiation
Following FACS, ALPL+/− cells and unsorted cells were
seeded in 96-well plates at 8,000 to 10,000 cells/well and
differentiated down the osteogenic lineage using the dif-
ferentiation medium described previously (N = 4, n = 16
each for osteogenic and control conditions for primed
ALPL+ cells, primed ALPL– cells, nonprimed ALPL– cells,
and unsorted cells; N = 2, n = 8 for nonprimed ALPL+ cells).
After 21 days, samples were fixed, stained, and quanti-
fied as described above. Calcified matrix deposition was
determined per sample, and then normalized within
donor groups to allow for relative comparisons among
sorted cell populations. Specifically, raw absorbance
Figure 1 Alkaline phosphatase liver/bone/kidney-based sorting method. Gene expression-based sorting of stromal vascular fraction (SVF)
cells involved a 4-day osteogenic priming period prior to sorting. Next, cells were treated by electroporation with molecular beacons targeting
alkaline phosphatase liver/bone/kidney (ALPL) mRNA. The beacon-treated cells were sorted using fluorescence-activated cell sorting (FACS) into
ALPL+ and ALPL– populations. A subset of the initial, primed, SVF cells was left unsorted. The ALPL+, ALPL–, and unsorted cells were seeded onto
tissue culture plates, differentiated down the osteogenic lineage, and assessed for production of calcified matrix.
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to the absorbance of their corresponding unsorted cells.
When not noted otherwise, results in this study are re-
ported using these per-sample, donor-normalized values. For
a subset of analyses, the raw absorbance values were also
normalized on a per-cell basis by counting the number
of Hoechst-stained nuclei per sample. In an additional ex-
periment, primed ALPL+/− cells and unsorted cells from
a representative donor (Donor 1) were differentiated down
the osteogenic, adipogenic, and chondrogenic lineages to
assess multipotency of the sorted populations (n = 4 per
subpopulation for osteogenesis, adipogenesis, and corre-
sponding control; n = 3 per subpopulation for chondro-
genesis and corresponding control).Surface marker-based sorting comparison
Surface marker-based fluorescence-activated cell sorting
SVF cells from a representative donor (Donor 1) were
freshly thawed, stained with trypan blue, and counted
with a hemocytometer to determine viability. Cells were
then washed twice in 4°C wash buffer (1× PBS, 1% bo-
vine serum albumin), resuspended, and incubated in 4°C
blocking buffer (1× PBS, 3% bovine serum albumin) for
10 minutes. Following a wash, cells were aliquoted into
separate tubes at a concentration of 105 cells/100 μl for
single color controls, negative controls, and sorting. Pre-
conjugated antibodies from BD Pharmingen against hu-
man CD34-FITC (#560942), human CD31-PE (#560983),
and human CD45-PE-Cy5 (#560974) were used to target
the ASC subpopulation [30,31]. The cells were incubated
with antibodies on ice for 20 minutes, followed by a
wash. The sort was performed on a BD FACS Influx,
and cytometry data were analyzed using FlowJo. Cells
were collected into a tube containing expansion medium
with 20% FBS.Differentiation of surface marker-sorted cells
Sorted CD34+/CD31−/CD45− cells were plated at a dens-
ity of 10,000 cells/well in a tissue culture-treated 96-well
plate. The cells were differentiated down the osteogenic
and adipogenic lineages (n = 4 for each lineage and cor-
responding controls), and differentiation was quantified
as described previously. Results were compared with
ALPL-based sorting to evaluate the relative effectiveness
of the two enrichment techniques.Statistical analysis
Significance in multipotency assessments for all four do-
nors was assessed using Student’s t test (P <0.05; differ-
entiated vs. control in osteogenic, adipogenic, and
chondrogenic conditions). Donor-specific experiments
were done iteratively to incorporate any systematic, run-
to-run error that might be present. Experiments involv-
ing ALPL-sorted cells differentiated down the osteogenic,
adipogenic, and chondrogenic lineages were assessed using
two-way analysis of variance (P <0.05; ALPL expression and
differentiation condition) with Holm–Sidak post hoc ana-
lyses on SigmaPlot software (SYSTAT Software, San
Diego, CA, USA). Lineage-specific differentiation response
for surface marker-sorted cells was assessed using Stu-
dent’s t test (P <0.05; differentiated vs. control in osteo-
genic and adipogenic conditions). Data are shown as
mean ± standard deviation.Results
Stromal vascular fraction isolation, cell yield, viability, and
multipotency
SVF cells were isolated from the fat tissue of four human
female donors with high yields and viabilities (Table 1). SVF
cells from all four donors exhibited multipotency down at
least two different lineages. Donors 1 to 3 could successfully








Donor 1 Breast cancer 87 74
Donor 2 Breast cancer 84 80
Donor 3 Breast cancer 99 95
Donor 4 Skin laxity 111 89
Average 95 ± 12 84 ± 9
Female donors ranging in age from 44 to 62 years old (mean ± standard
deviation, 51 ± 8). 250 mL of tissue processed per donor.
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drogenic lineages, whereas Donor 4 did not successfully
undergo chondrogenesis.ALPL-based sorting of stromal vascular fraction cells
SVF cells were successfully sorted based on ALPL gene
expression using a custom designed molecular beacon,
resulting in an average cell yield for primed ALPL+ cells
of 9 ± 3% of the input population (see Additional file 2).
Following standard FACS procedures, the input cell
population was gated using forward and side scatter
parameters, which eliminated aberrantly large or small
events (debris particles and cell aggregates; Figure 2).
For this gated population, sort data showed that, on
average, 34 ± 12% of cells displayed a positive beacon
signal (ALPL+) while 18 ± 7% had low/no signal (ALPL–;
see Additional file 2). To obtain distinct sort populations,
a gap was inserted between positive and negative groups
(Figure 2), which represented 48 ± 9% of the gated cells
(see Additional file 2). Decreasing the size of this gapFigure 2 Alkaline phosphatase liver/bone/kidney sort yields. Stromal v
kidney (ALPL) molecular beacon were sorted based on gene expression s
measurements to eliminate debris and cellular aggregates. (B) Nonprimed ce
the primed ALPL– peak. (C) Sorting was determined using the bimodal d
expressers (ALPL+) and negative expressers (ALPL–). A representative set o
6-carboxyfluorescein.would improve cell yields but might result in lower purity
for ALPL+/− sorted populations.Osteogenic differentiation across ALPL-sorted donors
ALPL+ cells deposited dramatically more calcified matrix
than unsorted or ALPL– cells under osteogenic conditions
(Figure 3A). In particular, primed ALPL+ cells induced for
osteogenesis displayed a strong propensity for osteogenic
matrix formation, showing 2.1-fold more calcified matrix
deposition than unsorted cells (P <0.05) and 3.7-fold more
than primed ALPL– cells (P <0.05). While significant vari-
ation existed among the four donors, these trends were
generally consistent, with ALPL+ samples exhibiting
more robust osteogenic responses (Figure 3B; see Additional
file 3). Unsorted samples did successfully differentiate and
produce calcified matrix, but the extent of matrix forma-
tion on a donor-normalized basis was much less than that
of the primed ALPL+ samples (Figure 4). Unsorted cells
deposited 0.9-fold more matrix than their matched, un-
differentiated controls, whereas primed ALPL+ cells de-
posited 5.1-fold more matrix than their undifferentiated
controls. Normalizing matrix deposition on a per-cell
basis revealed the same trends, suggesting that the sort-
ing process was successfully isolating individual cells
with increased synthetic capacity (Table 2).ALPL-based sorting and differentiation of passaged
human adipose-derived stem/stromal cells
Monolayer-expanded, passage 4 superlot ASCs were
sorted based on ALPL expression and differentiated
down the osteogenic lineage as described previously.
The yield of ALPL+ cells with respect to overall cellascular fraction cells treated with alkaline phosphatase liver/bone/
ignals. (A) Cells were first gated using forward and side scatter
lls were largely ALPL–, displaying a unimodal distribution overlapping with
istribution of primed SVF cells, with clear peaks existing for positive
f data is shown here for a single sorting experiment. 6-FAM,
Figure 3 Osteogenic differentiation of alkaline phosphatase
liver/bone/kidney-sorted stromal vascular fraction cells.
(A) Osteogenic ALPL+ cells produced significantly more matrix than
any other group. Raw absorbance values for all groups were normalized
within donors to their respective osteogenic, unsorted samples to allow
for relative comparisons. (B) While trends among sorted groups
remained the same when separating data by donor, extensive
variability in matrix production was observed, with some donor
cell populations being especially productive and others relatively
dormant. Two-way analysis of variance with Holm–Sidak post hoc
test determined significance among sorted groups (*P <0.05).
ALPL, alkaline phosphatase liver/bone/kidney.
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gated population being comprised of 81% ALPL+ cells and
12% ALPL– cells. Following osteogenic differentiation,
primed ALPL+ cells displayed a 1.2-fold increase in matrix
deposition over unsorted cells (P <0.05); however, raw ab-
sorbance values reflecting total calcified matrix amounts
per sample were on average one-tenth that observed forfreshly isolated SVF cells across all sorted groups and
donors.
Multipotency assessment of ALPL-sorted cells
To determine whether ALPL sorting isolated a unipotent
or multipotent cellular phenotype, additional lineages
beyond osteogenesis were assessed for primed ALPL+/−
and unsorted groups. ALPL+ cells were the only popula-
tion capable of adipogenesis (P <0.05; Figure 5A), with
lipid accumulation in unsorted and ALPL– samples not
changing significantly (P = 0.63 and P = 0.053, respect-
ively). ALPL+ cells showed a 1.3-fold increase in lipid
formation over unsorted cells (P <0.05). Chondrogenesis
was assessed by quantifying sGAG content normalized
to DNA. Both ALPL+ and unsorted samples showed
successful differentiation responses (P <0.05), whereas
ALPL– samples did not (P = 0.79; Figure 5B). ALPL+
cells produced 1.2-fold and 0.9-fold more sGAG than
unsorted cells and ALPL– cells, respectively (P <0.05).
Surface marker-based sorting and differentiation of
stromal vascular fraction cells
SVF cells were sorted using a traditional, surface
marker-based approach targeting the CD34+/31−/45−
ASC subpopulation and then differentiated down the
osteogenic and adipogenic lineages. CD34+/31−/45− cells
represented 4% of the overall SVF population and 14%
of the gated cell population (see Additional file 4). Fol-
lowing differentiation, the CD34+/31−/45− osteogenic
samples produced significantly less matrix than control
samples on a per-sample basis, indicating an unsuccess-
ful differentiation response (absorbance: 0.19 ± 0.02 vs.
0.23 ± 0.02, P <0.02; see Additional file 4). On a per-cell
basis, osteogenic samples had more matrix deposition
than controls, but this increase did not achieve signifi-
cance (absorbance: 0.22 ± 0.09 vs. 0.14 ± 0.02, P = 0.16).
CD34+/31−/45− adipogenic samples produced significantly
more lipids than control samples, indicating successful adi-
pogenesis (absorbance: 1.82 ± 0.31 vs. 0.58 ± 0.13, P
<0.05), and when normalized on a per-cell basis the
relationship remained the same, with adipogenic cells
producing significantly more matrix than control cells
(absorbance/cell: 4.47 ± 0.90 vs. 0.39 ± 0.11, P <0.05).
Discussion
The results of this study showed that ALPL+ cell popula-
tions undergoing osteogenesis could produce up to 4.9
times the calcified matrix of unsorted samples, while
also exhibiting increased differentiation potential for adi-
pogenic and chondrogenic lineages. We predicted that,
given the heterogeneous nature of SVF cells, only a small
subset would express ALPL in response to osteogenic
priming. However, results showed that, on average, 34%
Figure 4 Alizarin red S staining of osteogenically primed, sorted stromal vascular fraction cells. Primed, sorted SVF cells were
differentiated down the osteogenic lineage for 3 weeks and stained for calcified matrix deposition (control medium conditions shown
in insets). ALPL+ cells visually produced the most matrix, with very dense, consistent staining across the entire sample. ALPL– cells
produced the least matrix, with the stain appearing as a slight wash of orange–red across the culture surface. Unsorted cells produced
some matrix, but deposition was scattered, with some areas appearing very red and others unstained. Scale bar: 100 μm. ALPL, alkaline
phosphatase liver/bone/kidney.
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early osteogenic marker, indicated by a positive ALPL
molecular beacon fluorescence. Calcified matrix deposition
was significantly increased in ALPL+ cells compared with
both unsorted and surface marker-sorted stromal cells,
and these trends remained the same whether they were
assessed on a per-sample or per-cell basis. ALPL+ cells
showed increases in adipogenic and chondrogenic poten-
tial as well, indicating that they are not only multipotent
but represent a beneficial subpopulation for lineages be-
yond osteogenesis. Further, this ALPL+ subpopulation was
isolated with significantly higher yields than traditional
stem cell sorting approaches, representing a potentially
transformative method of cell enrichment for MSCs.
Fluorescent tagging of live-cell gene expression in this
study allowed for enrichment of SVF cells in a manner
similar to surface marker-based sorting. Gene expression-
based sorting is an advantageous method for cell enrich-
ment for several reasons. Because gene expression occurs
before protein translation, we are able to target cells earl-
ier in the differentiation process than is feasible with pro-
tein labeling. This paradigm-shifting approach had no
negative effect on cellular growth and differentiation, and
the ALPL-targeting probe is safely degraded by naturalTable 2 Raw osteogenic data for sorted and unsorted cell pop
Cell numbers/sample (×103)
Control Osteogenic C
Nonprimed ALPL+ 13.5 ± 4.2 11.2 ± 9.0 0.2
Primed ALPL+ 9.5 ± 3.2 11.0 ± 4.0 0.1
Unsorted 11.5 ± 3.4 15.0 ± 8.7 0.1
Primed ALPL– 7.4 ± 1.6 14.0 ± 4.7 0.1
Nonprimed ALPL– 9.2 ± 2.5 13.0 ± 5.5 0.1
Primed indicates cells received osteogenic differentiation medium prior to alkaline
Data for control and osteogenic media conditions are shown (mean ± standard devprocesses in the cells [22]. Most importantly, ALPL+ cells
were found to be a highly productive subpopulation
within the SVF and could be an excellent cell source to
target for regenerative therapies and basic research. To
gain further insight into the abilities and cellular compos-
ition of ALPL+ subpopulations, we tested the multilineage
differentiation capability of primed, sorted samples. Pre-
sumably, sorting based on osteogenic gene expression
after a 4-day priming period would result in a population
of cells geared towards osteogenic differentiation. As such,
we hypothesized that ALPL+ subpopulations would have
diminished multilineage differentiation capabilities. Inter-
estingly, ALPL+ subpopulations showed significant in-
creases not only in osteogenic metabolite production
but also in characteristic chondrogenic and adipogenic
molecules production. When subjected to a standard,
2-week adipogenic differentiation protocol, ALPL+
samples produced 2.3 times the amount of lipid compared
with unsorted samples. For chondrogenesis, ALPL+
samples possessed one-half the DNA content of un-
sorted samples while producing the same amount of
sGAG, suggesting that ALPL+ cells were potentially pro-
ducing double the sGAG per cell than unsorted cells.
These findings demonstrated that ALPL+ subpopulationsulations
Absorbance/sample Absorbance/10,000 cells
ontrol Osteogenic Control Osteogenic
1 ± 0.10 0.80 ± 0.21 0.15 ± 0.04 2.71 ± 4.76
4 ± 0.03 1.03 ± 0.87 0.16 ± 0.04 0.98 ± 0.64
6 ± 0.05 0.36 ± 0.19 0.14 ± 0.03 0.60 ± 0.81
1 ± 0.02 0.19 ± 0.04 0.15 ± 0.02 0.14 ± 0.03
3 ± 0.03 0.28 ± 0.22 0.15 ± 0.03 0.19 ± 0.11
phosphatase liver/bone/kidney (ALPL) sorting. Unsorted population was primed.
iation).
Figure 5 Multilineage differentiation of alkaline phosphatase liver/bone/kidney-sorted stromal vascular fraction cells. Primed, sorted
stromal vascular fraction subpopulations were differentiated down the adipogenic and chondrogenic lineages to determine multipotency. ALPL+
samples showed significant increases in metabolite production over ALPL– and unsorted samples for both (A) adipogenic and (B) chondrogenic
conditions. Of particular note, only ALPL+ samples showed a significant differentiation response for adipogenesis. ALPL– samples showed no
response for either lineage, and unsorted samples only differentiated for chondrogenesis. Two-way analysis of variance with Holm–Sidak post hoc
tests determined significance (*or nonmatching letters, P <0.05). ALPL, alkaline phosphatase liver/bone/kidney; sGAG, sulfated glycosaminoglycan.
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though the most notable improvement was still for osteo-
genesis. Further, we found that a 4-day priming period did
not fully commit cells to the osteogenic lineage, which is
consistent with previous reports [32].
Although ALPL-based sorting reliably isolates cells
capable of increased calcified matrix deposition, it is un-
clear whether the procedure captures cells with the
greatest synthetic potential or simply removes an inhibi-
tory population. If we isolated maximally synthetic cells,
then an additive relationship should be apparent among
sorted groups, with the output of the unsorted population
approximately equaling the sum of its contributing sub-
populations, primed ALPL+/− cells. Surprisingly, increases
in matrix production in ALPL+ cells did not linearly relate
to the percentage of cells removed from the initial popula-
tion. In ALPL+ samples, removing nonexpressing cells,
which represented about 18% of the SVF cells on average,
resulted in a 210% increase in matrix production. This dis-
proportionate increase may be due to beneficial intercellu-
lar communication among cells capable of differentiation,
which are enriched in ALPL+ cell populations compared
with ALPL– and unsorted samples. This hypothesis is
consistent with studies showing that osteogenic differ-
entiation in MSCs is dependent on intercellular com-
munication [33-35]. In comparison, matrix deposition
by ALPL– cells was less than that by unsorted cells, but
this difference was not statistically significant, indicat-
ing the cells still had some osteogenic capacity and
were probably not actively inhibiting the process. The
specific role of intercellular communication within the
sorted populations is yet to be examined.
Donor-to-donor variability is a continual obstacle in
assessing the robustness of a treatment or experimental
finding [36,37], so in this study we sorted cells from fourdifferent donors to demonstrate the broad applicability
of the enrichment procedure. As expected, each donor
population deposited variable amounts of calcified matrix
following osteogenic differentiation, with Donor 4 cells be-
ing the highest producers overall. Interestingly, unsorted
Donor 3 samples were unable to osteogenically differenti-
ate on a per-sample basis, but the ALPL+ subpopulation
overcame this lack of response with a robust, successful
differentiation. Similarly, while unsorted Donor 1 samples
were unable to differentiate significantly down the adipo-
genic lineage, contrary to results from initial multipotency
testing on this donor, the ALPL+ subpopulation exhibited
a positive differentiation response, indicating superior
differentiation capabilities of these sorted cells. Despite
differences among donors, gene expression-based sorting
consistently isolated highly productive subpopulations of
cells (ALPL+). The versatility of this procedure is apparent
regardless of innate donor differentiation ability.
Two of the donor SVF populations (Donors 3 and 4)
contained a subpopulation of cells that inherently expressed
ALPL, without any presort priming. Interestingly, non-
primed ALPL + cells performed similarly to primed ALPL+
cells in terms of matrix deposition, suggesting that some
donors may have a ready population of high-potential
osteogenic cells that can be isolated directly without need
for priming. Another contributor to variability may be the
morbidities associated with each donor. Notably, Do-
nors 1, 2, and 3 had previous breast cancer diagnoses,
while Donor 4 did not. Donor 4 cells displayed more ro-
bust osteogenic differentiation than the others, perhaps
due to being from a noncancerous donor. Regardless of
prior morbidity, all of the donors were found capable of
multilineage differentiation. This is especially encour-
aging, because it suggests that even prior pathology and
treatment regimens did not limit the differentiation
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tailed medical histories would be necessary to make any
specific hypotheses as to a donor-specific cause of any
differentiation differences. Future studies focusing on
donor population characteristics may help answer some
of these questions.
Surface marker-based sorting strategies are the gold
standard technique for cell enrichment. However, these
approaches typically produce cell yields significantly lower
than those obtained via our gene expression-based sorting
strategy. While the highest, reported MSC yields for
antigen-based sorting are ~30% of the gated population,
some of the more specific surface marker profiles limit
yields to <0.1% [17,31,38-41]. Also, in many cases the
assessed population may only represent a small portion
of the initial cell harvest because of restrictive gating for
size and granularity. In the current study, we also in-
cluded a gap region between positive and negative ALPL
population peaks to minimize contamination from the
other group. Because the peaks are often relatively near
each other, a large proportion of cells are sacrificed to
the gap (24 to 62% of cells). Refinements to the procedure,
such as using a more intense fluorophore with better
quenching, can further separate positive and negative
peaks, lessening the number of cells present in the gap re-
gion. Even with these limitations, the ALPL-based sorting
approach produced an overall 9% yield for ALPL+ cells
(34% of gated events). We also performed a representative
surface marker-based sorting experiment, which isolated
cells using a broad CD34+/CD31−/CD45− immunopheno-
type profile for ASCs [30]. Using this loose definition, ASCs
represented only 4% of the population, which is two-fifths
of the yield we obtained via gene expression-based sorting.
In addition to limited yield, CD34+/CD31−/CD45− cells dis-
played no increase in calcified matrix deposition when
compared with unsorted cells. We hypothesized that sur-
face marker-based sorting would isolate tightly defined,
highly differentiable subsets of the larger SVF population.
Surprisingly, we found that these cells demonstrated a
more limited ability to differentiate down the osteogenic
lineage than ALPL+ or unsorted cells. Because of the
rigorous, immunophenotype definitions characteristic
of surface marker-based sorting, it is possible that
other subpopulations of cells capable of differentiation
are excluded, resulting in diminished osteogenic cap-
abilities [13]. The broad inclusiveness of our gene
expression-based sorting procedure ensures that all
cells capable of osteogenic gene expression are cap-
tured, rather than a single immunophenotype. Others
have shown that a mixed population of cells may be
more beneficial to osteogenesis than a highly purified
stem-like population [42-44]. These results bolster the
notion that stem cell-specific sorting, which aims to
eliminate nonstem immunophenotypes, may actuallyimpair the overall regenerative potential of heteroge-
neous MSC populations.
In addition to experiments using primary cells, gene
expression-based sorting was also performed with highly
enriched, passaged ASCs comprised of a superlot of do-
nors. Researchers have shown that passaging freshly iso-
lated SVF cells results in enrichment for highly adherent
stem-like cells, since less adherent cell types, such as
endothelial and circulating hematopoietic cells, remain
detached from the culture surface [9,13]. Based on the
reported homogeneity of these passaged ASC populations,
we hypothesized that the majority of these cells would ex-
press ALPL in response to osteogenic growth factors and
that increases in osteogenic matrix deposition in ALPL+
cells compared with unsorted cells would be minimal. As
predicted, a larger proportion of cells exhibited a positive
beacon signal (81%) based on flow cytometry. Interest-
ingly, a significant increase in matrix deposition was still
observed for ALPL+ cells versus unsorted samples. This
observation was surprising because it indicated that even
supposedly pure ASC populations could be further
enriched for cells with enhanced osteogenic capabilities.
Despite the positive trends, however, superlot ASCs differ-
entiated poorly in comparison with freshly isolated cells,
producing 10 times less matrix than either sorted or un-
sorted primary SVF cells. Other researchers have also ac-
knowledged the drawbacks of using passaged stromal
cells for differentiation [45-47]. While the gene expression-
based sorting procedure does benefit the overall differenti-
ation response of passaged ASCs, our best results were
achieved using primary SVF-derived cells.
The gene expression-based sorting strategy demon-
strated in this study requires a 4-day osteogenic priming
period, which is nonideal for single-surgery therapeutic
applications. However, priming has been shown to be an
effective approach for inducing the expression of char-
acteristic molecules [48]. That said, refinements to our
strategy, such as targeting mRNA transcripts earlier in
the gene expression pathway, should be considered to
minimize or eliminate the priming period. However, the
increase in matrix production currently afforded to
sorted cells may offset drawbacks associated with cell
priming, and some donors may not even require this if
ALPL+ cells are inherently present at sufficient num-
bers. Another potential drawback of the sorting proced-
ure is the presence of false positive cells in the ALPL+
population, given that nonspecific fluorescence is a
known limitation of molecular beacons [22,49,50]. Des-
pite this potential source of error, ALPL + populations
still produced significantly more matrix than any other
population of SVF-derived cells, suggesting minimal
negative influence from the inclusion of some false-
positive cells. Improvements in beacon technology have
the potential to further improve outcomes by minimizing
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tions best when targeting abundant mRNA molecules,
because the high concentration of target transcripts
yields an easily defined positive signal. To target genes
that are expressed in low copy numbers, a different strat-
egy must be employed, with one possibility being binding
multiple probes to a single transcript to amplify positive
signals within the cell [51].
Conclusion
We have demonstrated that sorting stromal cells based
on expression of ALPL mRNA isolated a highly synthetic
ALPL + subpopulation with significantly improved osteo-
genesis capabilities. These cells produced more calcified
matrix than unsorted stromal cells and were collected in
higher yields than existing cell enrichment strategies.
ALPL+ cells also showed improved multilineage differen-
tiation capability over unsorted samples, indicating that
they are most probably a highly responsive subpopula-
tion within the SVF and not merely osteoprogenitors.
Furthermore, since this method improves the cell source
at the front end of tissue engineering and cell-based
therapies, downstream outcomes have the possibility to
see even greater gains. The significance of this work lies
in a potential paradigm shift in how cells can be identi-
fied and sorted using gene expression-based markers
with existing flow cytometry infrastructure. Both basic
science investigations and cell-based, clinical therapies
could realize significant improvements for applications
involving heterogeneous samples.
Note
This article is part of an ‘Emerging Investigators’ collection
showcasing the work of early career investigators who
have demonstrated growing leadership in the field of stem
cells and regenerative medicine. Other articles in the series
can be found online at http://stemcellres.com/series/
emerginginvestigators.
Additional files
Additional file 1: Figure S1. Showing a mock sort of gated SVF cells.
Donor 4 SVF cells were gated and sorted based on just forward (FSC) and side
(SSC) scatter parameters, to ensure that the initial gating process alone was
not enriching the cells. Gated osteogenic samples did not show any change
in calcified matrix production compared with unsorted osteogenic samples,
providing evidence that simply putting cells through the flow cytometer did
not affect osteogenic response to any significant extent (P = 0.89).
Additional file 2: Table S1. Presenting donor-specific yields for the
ALPL-sorting procedure.
Additional file 3: Figure S2. Showing donor-specific calcified matrix
production for sorted SVF cells. SVF cells from four, distinct donors were
sorted based on expression of ALPL mRNA. Absorbance values of eluted
alizarin red S, indicative of calcified matrix production, were normalized
on a per-cell basis by counting Hoechst 33342-stained nuclei in each
sample. In all donors, ALPL+ groups consistently produced more calcifiedmatrix on a per-cell basis than any other group. However, in Donor 4 the
overall matrix production was higher, and so primed ALPL+ cells were
not significantly more productive than unsorted cells (P = 0.97). Sample
groups with nonmatching letters are significantly different (P <0.05).
Additional file 4: Figure S3. Showing surface marker-based sorting of
SVF cells. Freshly thawed SVF cells were labeled with fluorescent antibodies
for CD34, CD31, and CD45 and sorted using a BD FACS Influx. (A) Gated
forward and side scatter cells were (B) 23% positive for CD34 surface antigen
expression. (C) Of the CD34+ cells, 58% were also CD31− and CD45−. Overall
yield for CD34+/31−/45− cells was 4%, and these cells displayed only a limited
ability to differentiate down the osteogenic lineage. (D) In comparison,
primed, ALPL+ cells produced 25-fold more calcified matrix than
CD34+/31−/45− cells. Sample groups with nonmatching letters are
significantly different (P <0.05).
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